Close

Optimer Pharma (OPTR) Reports Superior Performance from DIFICID Phase 3 vs. Oral Vancomycin

Go back to Optimer Pharma (OPTR) Reports Superior Performance from DIFICID Phase 3 vs. Oral Vancomycin